Compare ZLAB & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | PGNY |
|---|---|---|
| Founded | 2013 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2017 | 2019 |
| Metric | ZLAB | PGNY |
|---|---|---|
| Price | $18.37 | $17.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $49.44 | $27.10 |
| AVG Volume (30 Days) | 544.8K | ★ 1.7M |
| Earning Date | 05-29-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.46 | 14.04 |
| EPS | N/A | ★ 0.65 |
| Revenue | $460,156,000.00 | ★ $1,288,661,000.00 |
| Revenue This Year | $14.46 | $9.57 |
| Revenue Next Year | $29.47 | $10.06 |
| P/E Ratio | ★ N/A | $26.91 |
| Revenue Growth | ★ 15.33 | 10.40 |
| 52 Week Low | $15.96 | $16.76 |
| 52 Week High | $44.34 | $28.75 |
| Indicator | ZLAB | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 44.52 | 30.68 |
| Support Level | $16.77 | $16.76 |
| Resistance Level | $19.71 | $22.71 |
| Average True Range (ATR) | 0.76 | 0.99 |
| MACD | -0.11 | 0.00 |
| Stochastic Oscillator | 43.03 | 13.07 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.